Alison Slocum
About Alison Slocum
Alison Slocum is the Associate Director of CAR T Validation at Bristol Myers Squibb, with extensive experience in clinical operations and process validation.
Company
Alison Slocum is currently affiliated with Bristol Myers Squibb in Summit, New Jersey, United States. At this organization, she holds dual roles as the Associate Director of CAR T Validation and as a Senior Manager, Principal Specialist, Quality Assurance Process Validation. Prior to her tenure at Bristol Myers Squibb, she amassed significant experience at Memorial Sloan-Kettering Cancer Center and other reputable institutions.
Title
Alison Slocum is the Associate Director of CAR T Validation at Bristol Myers Squibb. In this capacity, she leads the site validation team and is responsible for the development and implementation of CAR T Process Validation programs.
Education and Expertise
Alison Slocum obtained her Master of Science in Molecular Biology from New York University, where she studied from 2005 to 2007. Prior to that, she completed a Bachelor of Science degree in Biology/Biological Sciences with a minor in Chemistry from the University of North Carolina Wilmington, graduating in 2003. Her academic background laid the foundation for her extensive expertise in biological sciences, particularly T-cell therapy.
Professional Background
Alison Slocum has a robust professional background that includes various roles at Memorial Sloan-Kettering Cancer Center from 2007 to 2019, such as Clinical Operations Manager, Clinical Operations Coordinator, and Senior Research Technician. Additionally, she has held positions at UCSF as a Staff Research Associate and at UNC Wilmington as a Research Fellow and Associate.
Achievements
Alison Slocum has demonstrated expertise in several key areas, including technology transfer related to T-cell therapy products and managing Phase I-III clinical trials of these products. At Bristol Myers Squibb, she oversees the design and implementation of Aseptic Process Simulation/Validation (APS/APV) for aseptic manufacturing processes and is deeply involved in clinical and commercial readiness activities.